Search Results

Viewing Page 9 of 22 | Showing Results 81 - 90 of 214

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment


Gary Goodman, MD
Swedish Cancer Institute

Phase 1/2 Open Label, Multi-center, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Fimepinostat (CUDC-907), a PI3K and HDAC Inhibitor, in Subjects With Refractory or Relapsed Lymphoma

This is a phase 1/2, open-label, dose-escalation study of fimepinostat (CUDC-907) in patients with relapsed and/or refractory lymphoma, relapsed...

Krish Patel, M.D.

Swedish Cancer Institute

T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer (T-DM1)

This is a randomized phase II study to evaluate if the combination of T-DM1 with palbociclib improves progression-free survival compared to single...

Henry Kaplan, MD

Swedish Cancer Institute

Swedish Cancer Institute Personalized Medicine Research Program

Over the years, cancer researchers and specialists are learning that not all cancers are alike and each cancer has its own unique features. Use of...

Philip Gold, MD
Swedish Cancer Institute

SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer

This randomized phase II trial studies how well surgical removal of the prostate and antiandrogen therapy with or without docetaxel work in...

James Porter, MD
Swedish Urology Group, PC 
1101 Madison St, Ste 1400 
Seattle, Washington 98104

Swedish Medical Center
747 Broadway
Seattle, WA 98122
Viewing Page 9 of 22 | Showing Results 81 - 90 of 214